ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · Real-Time Price · USD
4.380
-0.020 (-0.45%)
Dec 20, 2024, 4:00 PM EST - Market closed
ReShape Lifesciences Employees
ReShape Lifesciences had 29 employees as of December 31, 2023. The number of employees decreased by 11 or -27.50% compared to the previous year.
Employees
29
Change (1Y)
-11
Growth (1Y)
-27.50%
Revenue / Employee
$282,172
Profits / Employee
-$243,690
Market Cap
3.12M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
InMed Pharmaceuticals | 13 |
Azitra | 10 |
Entero Therapeutics | 9 |
NLS Pharmaceutics AG | 7 |
Artelo Biosciences | 6 |
Titan Pharmaceuticals | 4 |
Tharimmune | 3 |
Alaunos Therapeutics | 1 |
RSLS News
- 5 weeks ago - ReShape Lifesciences Inc. (RSLS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update - GlobeNewsWire
- 5 weeks ago - ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX - GlobeNewsWire
- 5 weeks ago - ReShape Lifesciences® Receives NIH Supplementary Grant with the University of Southern California's Center for Autonomic Nerve Recording and Stimulation Systems (CARSS) to Further Develop Next-Generation Electrodes for ReShape's Proprietary Diabetes Bloc-Stim Neuromodulation™ Technology - GlobeNewsWire
- 3 months ago - ReShape Lifesciences Announces 1-for-58 Reverse Stock Split - GlobeNewsWire
- 4 months ago - ReShape Lifesciences Inc. (RSLS) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update - GlobeNewsWire
- 5 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHUY, RSLS on Behalf of Shareholders - GlobeNewsWire